Ritz Pharmaceutical And Foods Products Profile
Key Indicators
- Authorised Capital ₹ 0.22 M
- Paid Up Capital ₹ 0.20 M
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.09%
- Profit Growth -142.96%
- Ebitda -22.38%
- Net Worth -3.77%
- Total Assets 41.18%
About Ritz Pharmaceutical And Foods Products
Ritz Pharmaceutical And Foods Products Private Limited (RPAFPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 1986 and has a history of 38 years and nine months. Its registered office is in Uttar Prdesh, Uttar Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.22 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gupta and Kapil Gupta serve as directors at the Company.
Company Details
- Location Uttar Prdesh, Uttar Pradesh
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232UP1986PTC007863
-
Company No.
007863
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 1986
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Ritz Pharmaceutical And Foods Products?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta
|
Managing Director | 02-Jun-2001 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kapil Gupta
|
Director | 24-Jan-2011 | Current |
Financial Performance of Ritz Pharmaceutical And Foods Products.
Ritz Pharmaceutical And Foods Products Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 0.09% increase. The company also saw a substantial fall in profitability, with a 142.96% decrease in profit. The company's net worth dipped by a decrease of 3.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ritz Pharmaceutical And Foods Products?
In 2017, Ritz Pharmaceutical And Foods Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ritz Pharmaceutical And Foods Products?
Unlock and access historical data on people associated with Ritz Pharmaceutical And Foods Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ritz Pharmaceutical And Foods Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritz Pharmaceutical And Foods Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
